Emerging concepts in cardiovascular disease risk assessment: Where do women fit in?

Journal of the American Academy of Nurse Practitioners

Volumn 21, Issue 9, 2009, Pages 480-487

  Gleeson, Deborah ^a,b   Crabbe, Deborah L ^a,c  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b Temple University Health Sciences Center   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease prevention; Risk assessment; Risk factors; Sex differences; Women

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; METHODOLOGY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WOMEN'S HEALTH;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; WOMEN'S HEALTH;

EID: 69749086181     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2009.00434.x     Document Type: Article

References (52)

1. Abbott, R. D., Donahue, R. P., Kannel, W. B., & Wilson, P. W. (1988). The impact of diabetes on survival following myocardial infarction in men vs. women. The Framingham study. Journal of the American Medical Association, 260 (23 3456 3460.
2. Ahluwalia, I. B., Mack, K. A., Murphy, W., Mokdad, A. H., & Bales, V. S. (2003). State-specific prevalence of selected chronic disease-related characteristics -Behavioral Risk Factor Surveillance System, 2001. Morbidity & Mortality Weekly Reports Surveillance Summary, 52 (8 1 80.
3. Alpert, J. S., & Leier, C. V. (1999). 30th Bethesda Conference: The future of academic cardiology. Task force 4: faculty. Journal of the American College of Cardiology, 33 (5 1127 1135.
4. Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007). Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Journal of the American Medical Association, 298 (3 309 316.
5. Bello, N., & Mosca, L. (2004). Epidemiology of coronary heart disease in women. Progress in Cardiovascular Diseases, 46 (4 287 295.
6. Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., et al. (1995). Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension, 25 (3 305 313.
7. Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R, et al. (2004). Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New England Journal of Medicine, 350 (15 1495 1504.
8. Christian, A. H., Rosamond, W., White, A. R., & Mosca, L. (2007). Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: An American Heart Association national study. Journal of Women's Health (Larchmont), 16 (1 68 81.
9. Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A., Livingstone, S, et al. (2004). Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet, 364 (9435 685 696.
10. Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., et al. (2001). Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Archives of Internal Medicine, 161 (11 1413 1419.
11. Danik, J. S., Rifai, N., Buring, J. E., & Ridker, P. M. (2006 Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. Journal of the American Medical Association, 296 (11 1363 1370.
12. Dubey, R. K., Oparil, S., Imthurn, B. & Jackson, E. K. (2002). Sex hormones and hypertension. Cardiovascular Research, 53 (3 688 708.
13. Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults. Journal of the American Medical Association, 287, 356 359.
14. Froelicher, E. S., Miller, N. Christopherson, D. J., Martin K., Parker, K. M., Armonetti M. et al (2004). High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: The women's initiative for nonsmoking (WINS). Circulation, 109, 587 593.
15. Froelicher, E. S., Sohn, M., Max, W., & Bacchetti, P. (2004). Women's Initiative for Nonsmoking-VII: Evaluation of health service utilization and costs among women smokers with cardiovascular disease. Journal of Cardiopulmonary Rehabilitation, 24 (4 218 228.
16. Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., & Somers, V. K., et al. (2007). Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. Journal of the American College of Cardiology, 49 (4 403 414.
17. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., et al. (2002). Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Journal of the American Medical Association, 288 (1 49 57. (Pubitemid 34705518)
18. Grundy, S. M., Hansen, B., Smith, S. C. Jr., Cleeman, J. I., & Kahn, R. (2004). Clinical management of metabolic syndrome report of the American Heart Association /National Heart Lung and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation, 109, 551 556.
19. Heart Protection Study Collaborative Group 2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360 (9326 7 22.
20. Ho, K., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy D. (1993). Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation, 88, 107 115.
21. Ho, K., Pinsky, J. L, Kannel, W. B., & Levy, D. (1993). The epidemiology of heart failure: The Framingham study. Journal of the American College of Cardiology, 22 (Suppl. A 6A 13A.
22. Hsia, J., Margolis, K. L., Eaton, C. B., Wenger, N. K., Allison, M., Wu, L., et al. (2007). Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation, 115 (7 855 860. (Pubitemid 46294726)
23. Hulley S, Grady D., Bush T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) research group. Journal of the American Medical Association, 280 (7 605 613.
24. Koenig, W., Lowel, H., Baumert, J., & Meisinger, C. (2004). C-reactive protein modulates risk prediction based on the Framingham score: Implications for future risk assessment: Results from a large cohort study in southern Germany. Circulation, 109 (11 1349 1353.
25. LaRosa, J. C. (2003). Evidence-based management of dyslipidemias in women. Current Atherosclerosis Report, 5 (5 379 385.
26. Liao, Y, Cooper, R. S., Mensah G. A, & McGee, D. L. (1995). Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation, 92 (4 805 810.
27. Lindenfeld, J., Krause-Steinrauf, H, & Salerno, J. (1997). Where are all the women with heart failure? Journal of the American College of Cardiology, 30, 1417 1419.
28. Lloyd-Jones, D. M., Leip, E. P., Larson, M. G., D'Agostino, R. B., Beiser, A., Wilson, P. W., et al. (2006). Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation, 113 (6 791 798.
29. Lloyd-Jones, D. M., Sutton-Tyrrell, K., Patel, A. S., Matthews, K. A., Pasternak, R. C., Everson-Rose, S. A., et al. (2005). Ethnic variation in hypertension among premenopausal and perimenopausal women: Study of Women's Health Across the Nation. Hypertension, 46 (4 689 695.
30. Masoudi F. A, Havranek, E. P., Smith, G., Fish, R. H., Steiner, J. F., Ordin, D. L., et al. (2003). Gender, age and heart failure with preserved left ventricular systolic function. Journal of the American College of Cardiology, 41 (2 217 223. (Pubitemid 36092188)
31. Michos, E. D., Nasir, K., Braunstein, J. B., Rumberger, J. A., Budoff, M. J., Post W. S. et al. (2006). Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis, 184 (1 201 206.
32. Michos, E. D., Vasamreddy, C. R., Becker, D. M., Yanek, L. R., Moy, T. F., Fishman, E. K., et al. (2005). Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. American Heart Journal, 150 (6 1276 1281.
33. Miller, M. (2003). Niacin as a component of combination therapy for dyslipidemia. Mayo Clinic Proceedings, 78 (6 735 742.
34. Mora, S., Lee, I. M., Buring, J. E., & Ridker, P. M. (2006). Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. Journal of the American Medical Association, 295 (12 1412 1419.
35. Mora, S., Redberg, R. F., Sharrett, A. R., & Blumenthal, R. S. (2005). Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores. Circulation, 112 (11 1566 1572.
36. Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., et al. (2004). Evidence-based guidelines for cardiovascular disease prevention in women. Circulation, 109, 672 693. (Pubitemid 38198877)
37. Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., et al. (2007). Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation, 115 (11 1481 1501. (Pubitemid 46648385)
38. Mosca, L., Linfante, A. H., Benjamin, E. J., Berra, K., Hayes, S. N., Walsh, B. W., et al. (2005). National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation, 111 (4 499 510.
39. Mosca, L., Mochari, H., Christian, A., Berra, K., Taubert, K., Mills, T., et al. (2006). National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation, 113 (4 525 534.
40. Nasir, K., Michos, E. D., Blumenthal, R. S., & Raggi, P. (2005). Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. Journal of the American College of Cardiology, 46 (10 1931 1936.
41. Park, Y., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003). The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Archives of Internal Medicine, 163, 427 346.
42. Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation, 107 (3 391 397.
43. Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007). Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. Journal of the American Medical Association, 297 (6 611 619.
44. Robertson, R. (2001). Women and cardiovascular disease: The risks of misperception and the need for action. Circulation, 103 (19 2318 2326.
45. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., et al. (2008). Heart disease and stroke statistics -2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117 (4 e25 e146.
46. Schillaci, G., Verdecchia, P., Porcellati, C., Cuccurullo, O., Cosco, C., & Perticone, F. (2000). Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension, 35, 580 586.
47. Sciammanna, C. N., Alvarez K., Miller, J., Gary, T., & Bowen, M. (2006 Attitudes toward nurse practitioner-led chronic disease management to improve outpatient quality of care. American Journal of Medical Quality, 21, 375 381.
48. Shlipak, M. G., Simon, J. A., Grady, D., Lin, F., Wenger, N. K., & Furberg, C. D. (2001). Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. Journal of the American College of Cardiology, 38 (3 705 711.
49. Sibley, C., Blumenthal, R. S., Merz, C. N., & Mosca, L. (2006). Limitations of current cardiovascular disease risk assessment strategies in women. Journal of the Women's Health (Larchmont), 15 (1 54 56.
50. Sowers, J. (1998). Diabetes mellitus and cardiovascular disease in women. Archives of Internal Medicine, 158 (6 617 621. (Pubitemid 28144819)
51. Stone, P., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., et al. (1989). The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. Journal of the American College of Cardiology, 14, 49 57.
52. Women's Health Initiative Investigators 2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Journal of the American Medical Association, 288 (3 321 333.